14159 Capital (gp), Llc - Net Worth and Insider Trading

14159 Capital (gp), Llc Net Worth

The estimated net worth of 14159 Capital (gp), Llc is at least $108 Million dollars as of 2024-05-06. 14159 Capital (gp), Llc is the Director, 10% Owner of Seagen Inc and owns about 323,148 shares of Seagen Inc (SGEN) stock worth over $74 Million. 14159 Capital (gp), Llc is the Director, 10% Owner of Incyte Corp and owns about 355,839 shares of Incyte Corp (INCY) stock worth over $19 Million. 14159 Capital (gp), Llc is also the Director, 10% Owner of Genomic Health Inc and owns about 227,840 shares of Genomic Health Inc (GHDX) stock worth over $14 Million. Besides these, 14159 Capital (gp), Llc also holds BioCryst Pharmaceuticals Inc (BCRX) . Details can be seen in 14159 Capital (gp), Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that 14159 Capital (gp), Llc has not made any transactions after 2012-03-08 and currently still holds the listed stock(s).

Transaction Summary of 14159 Capital (gp), Llc

To

14159 Capital (gp), Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, 14159 Capital (gp), Llc owns 8 companies in total, including Ocera Therapeutics Inc (OCRX) , XOMA Corp (XOMA) , and Incyte Corp (INCY) among others .

Click here to see the complete history of 14159 Capital (gp), Llc’s form 4 insider trades.

Insider Ownership Summary of 14159 Capital (gp), Llc

Ticker Comapny Transaction Date Type of Owner
OCRX Ocera Therapeutics Inc 2012-03-12 10 percent owner
XOMA XOMA Corp 2012-03-06 10 percent owner
INCY Incyte Corp 2012-01-13 director
2011-09-06 director & 10 percent owner
2009-10-19 10 percent owner
2007-08-06 10 percent owner
2006-03-24 10 percent owner
2012-03-06 10 percent owner

14159 Capital (gp), Llc Latest Holdings Summary

14159 Capital (gp), Llc currently owns a total of 4 stocks. Among these stocks, 14159 Capital (gp), Llc owns 323,148 shares of Seagen Inc (SGEN) as of September 6, 2011, with a value of $74 Million and a weighting of 68.4%. 14159 Capital (gp), Llc owns 355,839 shares of Incyte Corp (INCY) as of January 13, 2012, with a value of $19 Million and a weighting of 17.7%. 14159 Capital (gp), Llc also owns 227,840 shares of Genomic Health Inc (GHDX) as of March 8, 2012, with a value of $14 Million and a weighting of 13.38%. The other 1 stocks BioCryst Pharmaceuticals Inc (BCRX) have a combined weighting of 0.52% among all his current holdings.

Latest Holdings of 14159 Capital (gp), Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2011-09-06 323,148 228.74 73,916,874
INCY Incyte Corp 2012-01-13 355,839 53.76 19,129,905
GHDX Genomic Health Inc 2012-03-08 227,840 63.44 14,454,170
BCRX BioCryst Pharmaceuticals Inc 2007-08-06 127,361 4.45 566,756

Holding Weightings of 14159 Capital (gp), Llc


14159 Capital (gp), Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, 14159 Capital (gp), Llc has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the acquisition of 1,773 shares on September 6, 2011, which cost 14159 Capital (gp), Llc around $30,283.

According to the SEC Form 4 filings, 14159 Capital (gp), Llc has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the acquisition of 14,625 shares on January 13, 2012, which cost 14159 Capital (gp), Llc around $239,411.

According to the SEC Form 4 filings, 14159 Capital (gp), Llc has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the acquisition of 1,099 shares on March 8, 2012, which cost 14159 Capital (gp), Llc around $33,091.

More details on 14159 Capital (gp), Llc's insider transactions can be found in the Insider Trading History of 14159 Capital (gp), Llc table.

Insider Trading History of 14159 Capital (gp), Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

14159 Capital (gp), Llc Trading Performance

GuruFocus tracks the stock performance after each of 14159 Capital (gp), Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by 14159 Capital (gp), Llc is 10.91%. GuruFocus also compares 14159 Capital (gp), Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by 14159 Capital (gp), Llc within 3 months outperforms 61 times out of 91 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how 14159 Capital (gp), Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of 14159 Capital (gp), Llc

Average Return

Average return per transaction

Outperforming Transactions

65 out of 91 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.66
Relative Return to S&P 500(%) 2.49

14159 Capital (gp), Llc Ownership Network

Ownership Network List of 14159 Capital (gp), Llc

No Data

Ownership Network Relation of 14159 Capital (gp), Llc


14159 Capital (gp), Llc Owned Company Details

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

14159 Capital (gp), Llc is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocera Therapeutics Inc Insider Transactions

No Available Data

14159 Capital (gp), Llc Mailing Address

Above is the net worth, insider trading, and ownership report for 14159 Capital (gp), Llc. You might contact 14159 Capital (gp), Llc via mailing address: 667 Madison Ave, 21st Floor, New York Ny 10065.

Discussions on 14159 Capital (gp), Llc

No discussions yet.